William Blair & Company

Montrose Environmental Group Announces Pricing of Public Offering of Shares

Retrieved on: 
Thursday, April 18, 2024
Green Technology, Manufacturing, Environment, Engineering, Sustainability, Movement, Sale, William Blair & Company, Prospectus, Acceleration, Broadridge Financial Solutions, MEG, Security (finance), Form S-3, Research, Public expenditure, Form, Equity capital markets, Evercore, Intellectual property, Capital One, BofA Securities, Attention, Telephone, File

Montrose Environmental Group, Inc. (the “Company” or “Montrose”) (NYSE: MEG) announced today the pricing of the previously announced underwritten public offering by the Company of 3,000,000 shares of its common stock at a price of $37.15 per share (before underwriting discounts and commissions).

Key Points: 
  • Montrose Environmental Group, Inc. (the “Company” or “Montrose”) (NYSE: MEG) announced today the pricing of the previously announced underwritten public offering by the Company of 3,000,000 shares of its common stock at a price of $37.15 per share (before underwriting discounts and commissions).
  • The Company has also granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock.
  • All of the securities to be sold in the offering are being offered by the Company.
  • The offering is expected to close on April 22, 2024, subject to the satisfaction of customary closing conditions.

Montrose Environmental Group Announces Public Offering of Shares

Retrieved on: 
Tuesday, April 16, 2024
Green Technology, Manufacturing, Environment, Engineering, Sustainability, Movement, Sale, William Blair & Company, Prospectus, Acceleration, Broadridge Financial Solutions, MEG, Security (finance), Form S-3, Research, Public expenditure, Form, Equity capital markets, Evercore, Intellectual property, BofA Securities, Attention, Telephone, File

Montrose Environmental Group, Inc. (the “Company” or “Montrose”) (NYSE: MEG) announced today that it intends to offer for sale 3,000,000 shares of its common stock in an underwritten public offering.

Key Points: 
  • Montrose Environmental Group, Inc. (the “Company” or “Montrose”) (NYSE: MEG) announced today that it intends to offer for sale 3,000,000 shares of its common stock in an underwritten public offering.
  • All of the securities to be sold in the offering are being offered by the Company.
  • In addition, the Company will grant the underwriters a 30-day option to purchase up to an additional 450,000 shares of common stock.
  • J.P. Morgan, William Blair and Evercore ISI are acting as joint leading book-running managers and representatives of the underwriters for the offering.

MSA Safety Welcomes Larry De Maria Executive Director, Investor Relations

Retrieved on: 
Thursday, April 25, 2024
William Blair & Company, Safety, MSA, Research, Stifel, Prudential Securities, Sterne, Corporate development, MSA Safety, Senior, Acquisition, CFA, Research fellow, Management

PITTSBURGH, April 25, 2024 /PRNewswire/ -- MSA Safety, Incorporated (NYSE: MSA), a global leader in the development of advanced safety products and solutions that protect people and facility infrastructures, has named Larry De Maria, CFA, as its Executive Director, Investor Relations.

Key Points: 
  • PITTSBURGH, April 25, 2024 /PRNewswire/ -- MSA Safety, Incorporated (NYSE: MSA), a global leader in the development of advanced safety products and solutions that protect people and facility infrastructures, has named Larry De Maria, CFA, as its Executive Director, Investor Relations.
  • Mr. De Maria joins MSA Safety from William Blair & Company where he served as Group Head, Global Industrial Infrastructure, Equity Research.
  • "As a highly respected analyst who has followed MSA Safety for more than five years, Larry brings to this position an extensive understanding of our business and the investor landscape.
  • Chris Hepler, who has served as Executive Director of Corporate Development and Investor Relations since 2021, will now lead MSA's corporate development function.

Buyers Edge Platform Announces $425M Preferred Equity Investment Led by General Atlantic Credit’s Atlantic Park Fund, Alongside Blackstone Tactical Opportunities and Morgan Stanley Tactical Value

Retrieved on: 
Monday, April 8, 2024
Supply Chain Management, Technology, Professional Services, Food, Beverage, Other Technology, Asset Management, Retail, Software, Restaurant, Bar, Food Tech, Finance, Culture, Supply chain management, Digital, Bregal Sagemount, Partnership, William Blair & Company, Senior, General Atlantic, Family, Cryptocurrency

Buyers Edge Platform (the “Company”), a leader in digital procurement solutions for the foodservice industry, today announced a $425M preferred equity investment from a consortium led by General Atlantic Credit’s (“GA Credit”) Atlantic Park fund, alongside funds managed by Blackstone Tactical Opportunities (“Blackstone”) and investment funds managed by Morgan Stanley Tactical Value (“MS Tactical Value”).

Key Points: 
  • Buyers Edge Platform (the “Company”), a leader in digital procurement solutions for the foodservice industry, today announced a $425M preferred equity investment from a consortium led by General Atlantic Credit’s (“GA Credit”) Atlantic Park fund, alongside funds managed by Blackstone Tactical Opportunities (“Blackstone”) and investment funds managed by Morgan Stanley Tactical Value (“MS Tactical Value”).
  • Buyers Edge Platform was founded in 1998 with the mission of revolutionizing the foodservice industry through technology, purchasing power, and partnership.
  • Buyers Edge Platform partners with stakeholders across the industry value chain, including operators, distributors, and manufacturers, providing data visibility and purchasing transparency.
  • J.P. Morgan Securities LLC and William Blair & Company, LLC served as placement agents to Buyers Edge Platform.

Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement

Retrieved on: 
Friday, April 5, 2024
Biotechnology, Technology, Health, General Health, Pharmaceutical, Health Technology, Other Science, Research, Artificial Intelligence, Science, Clinical Trials, Vanderbilt Avenue, Canaccord Genuity, Form, Telephone, William Blair & Company, Sale, Attention, Security (finance), Prospectus, Suite, Form S-3

Subject to Biodesix stockholder approval, each share of Series A Non-Voting Convertible Preferred Stock will automatically convert to 40 shares of common stock for an aggregate of 30,434,280 shares of common stock.

Key Points: 
  • Subject to Biodesix stockholder approval, each share of Series A Non-Voting Convertible Preferred Stock will automatically convert to 40 shares of common stock for an aggregate of 30,434,280 shares of common stock.
  • The gross proceeds to Biodesix from the underwritten offering and concurrent private placement, before deducting underwriting discounts and commissions, placement agent fees and other offering expenses payable by Biodesix, and following the receipt of stockholder approval, are expected to be $55.0 million.
  • TD Cowen, William Blair and Canaccord Genuity are acting as joint bookrunning managers for the underwritten offering and placement agents for the concurrent private placement.
  • Lake Street Capital Markets is acting as lead manager for the underwritten offering and placement agent for the concurrent private placement.

Stevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary Shares

Retrieved on: 
Tuesday, March 26, 2024
Medical Supplies, Health, Medical Devices, Other Health, General Health, Pharmaceutical, Biotechnology, Citigroup, BofA Securities, Exercise, Offering, Form, Telephone, Stevanato Group, William Blair & Company, Sale, Attention, Security (finance), Prospectus, Morgan Stanley, KeyBank, Varick Street, 2nd Floor

Stevanato Group sold 7,302,500 ordinary shares (the “Company Offering”), and Stevanato Holding S.r.l., an affiliate and major shareholder of the Company (the “Selling Shareholder”), sold 7,302,500 ordinary shares (the “Selling Shareholder Offering” and, together with the Company Offering, the “Offering”).

Key Points: 
  • Stevanato Group sold 7,302,500 ordinary shares (the “Company Offering”), and Stevanato Holding S.r.l., an affiliate and major shareholder of the Company (the “Selling Shareholder”), sold 7,302,500 ordinary shares (the “Selling Shareholder Offering” and, together with the Company Offering, the “Offering”).
  • The total gross proceeds from the Offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $379.7 million, or approximately $189.8 million from each of the Company Offering and the Selling Shareholder Offering.
  • Stevanato Group will not receive any proceeds from the Selling Shareholder Offering.
  • Morgan Stanley and William Blair served as lead book-running managers and as representatives of the underwriters for the Offering.

Stevanato Group Announces Pricing of Upsized Public Offering of Ordinary Shares

Retrieved on: 
Friday, March 22, 2024
Medical Supplies, Health, Medical Devices, Other Health, General Health, Pharmaceutical, Biotechnology, Citigroup, BofA Securities, Exercise, Offering, Form, Telephone, Stevanato Group, William Blair & Company, Sale, Attention, Security (finance), Prospectus, Morgan Stanley, KeyBank, Varick Street, 2nd Floor

Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the pricing of its upsized underwritten public offering of an aggregate of 12,700,000 of its ordinary shares at a public offering price of $26.00 per share.

Key Points: 
  • Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the pricing of its upsized underwritten public offering of an aggregate of 12,700,000 of its ordinary shares at a public offering price of $26.00 per share.
  • Stevanato Group is offering 6,350,000 ordinary shares (the “Company Offering”), and Stevanato Holding S.r.l., an affiliate and major shareholder of the Company (the “Selling Shareholder”), which currently holds approximately 78% of Stevanato Group’s outstanding ordinary shares, is offering 6,350,000 ordinary shares (the “Selling Shareholder Offering” and, together with the Company Offering, the “Offering”).
  • Stevanato Group and the Selling Shareholder have granted the underwriters an option, exercisable for 30 days after the date of the final prospectus supplement, to purchase up to 1,905,000 additional ordinary shares on the same terms and conditions.
  • Stevanato Group will not receive any proceeds from the Selling Shareholder Offering.

Stevanato Group Announces Public Offering of Ordinary Shares

Retrieved on: 
Wednesday, March 20, 2024
Medical Supplies, Health, Medical Devices, Research, Science, Pharmaceutical, Biotechnology, Form, Telephone, Stevanato Group, William Blair & Company, Sale, Attention, Security (finance), Prospectus, Morgan Stanley, Varick Street, 2nd Floor

Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the launch of an underwritten public offering of an aggregate of $300,000,000 of its ordinary shares.

Key Points: 
  • Stevanato Group S.p.A. (NYSE: STVN) (“Stevanato Group,” or the “Company”), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, today announced the launch of an underwritten public offering of an aggregate of $300,000,000 of its ordinary shares.
  • Stevanato Group is offering $150,000,000 of its ordinary shares (the “Company Offering”), and Stevanato Holding S.r.l., an affiliate and major shareholder of the Company (the “Selling Shareholder”), which currently holds approximately 78% of Stevanato Group’s outstanding ordinary shares, is offering $150,000,000 of its ordinary shares (the “Selling Shareholder Offering” and, together with the Company Offering, the “Offering”).
  • Stevanato Group and the Selling Shareholder also intend to grant the underwriters an option, exercisable for 30 days after the date of the final prospectus supplement, to purchase additional ordinary shares up to an amount equal to 15% of the aggregate number of ordinary shares offered in the Offering on the same terms and conditions.
  • Stevanato Group intends to use the net proceeds from the Company Offering for general corporate purposes, including to enable Stevanato Group to satisfy the requirements of its ongoing investment activities and working capital needs, and to ensure an appropriate level of operating and strategic flexibility.

SharkNinja Announces Pricing of Secondary Offering of Ordinary Shares

Retrieved on: 
Tuesday, March 19, 2024
Technology, Retail, Home Goods, Consumer Electronics, BofA Securities, J. P. Morgan, Madison Avenue, Telephone, William Blair & Company, Sale, Attention, Security (finance), Guggenheim Partners, Prospectus, Morgan Stanley, Jefferies, Varick Street, Jefferies Group, 2nd Floor

SharkNinja, Inc. (NYSE: SN), a global product design and technology company, today announced the pricing of the previously announced secondary offering of 4,691,899 ordinary shares of SharkNinja by certain selling shareholders affiliated with Xuning Wang (collectively, the “Selling Shareholders”) at a price to the public of $58.00 per ordinary share.

Key Points: 
  • SharkNinja, Inc. (NYSE: SN), a global product design and technology company, today announced the pricing of the previously announced secondary offering of 4,691,899 ordinary shares of SharkNinja by certain selling shareholders affiliated with Xuning Wang (collectively, the “Selling Shareholders”) at a price to the public of $58.00 per ordinary share.
  • The Selling Shareholders granted the underwriters a 30-day option to purchase up to an additional 703,785 ordinary shares of SharkNinja.
  • SharkNinja is not selling any ordinary shares in the offering and will not receive any of the proceeds from the sale.
  • Goldman Sachs & Co. LLC, J.P. Morgan, Jefferies and Morgan Stanley are acting as joint lead book-running managers for the offering.

SharkNinja Announces Launch of Secondary Offering of Ordinary Shares

Retrieved on: 
Monday, March 18, 2024
Online Retail, Retail, Other Consumer, Consumer, Technology, Home Goods, Other Technology, BofA Securities, J. P. Morgan, Madison Avenue, Form, Telephone, William Blair & Company, Sale, Attention, Security (finance), Guggenheim Partners, Prospectus, Morgan Stanley, Jefferies, Varick Street, Jefferies Group, 2nd Floor

Additionally, the Selling Shareholders intend to grant the underwriters a 30-day option to purchase up to an additional 703,785 ordinary shares of SharkNinja.

Key Points: 
  • Additionally, the Selling Shareholders intend to grant the underwriters a 30-day option to purchase up to an additional 703,785 ordinary shares of SharkNinja.
  • SharkNinja is not selling any ordinary shares in the offering and will not receive any of the proceeds from the sale.
  • Goldman Sachs & Co. LLC, J.P. Morgan, Jefferies and Morgan Stanley are acting as joint lead book-running managers for the proposed offering.
  • The proposed offering of these securities will be made only by means of a prospectus.